This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Bimal K Das: Innovator in Rotavirus Research
Introduction
Bimal K Das is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of virology, particularly in the study of rotaviruses. His work has implications for public health, especially in the context of immunization protocols.
Latest Patents
Bimal K Das holds a patent for the rotavirus strain G9P11. This patent includes an isolated rotavirus of the strain G9P11, an isolated nucleic acid encoding the rotavirus, and a purified antigen specific for the rotavirus. Additionally, it provides an isolated nucleic acid that selectively hybridizes under high stringency conditions with the nucleic acid encoding the virus. The patent also includes a purified antibody that selectively binds the virus of strain G9P11. Furthermore, the G9P11 rotavirus is presented in a pharmaceutically acceptable carrier for administration in an immunization protocol. The patent details also mention an isolated rotavirus of strain G9P11, wherein the G gene and the P11 gene are substituted.
Career Highlights
Bimal K Das has had a distinguished career, working with the United States of America as represented by the Department of Health. His research has been pivotal in advancing the understanding of rotavirus and its implications for vaccine development.
Collaborations
He has collaborated with notable colleagues such as Roger I Glass and John R Gentsch, contributing to a collective effort in rotavirus research and public health initiatives.
Conclusion
Bimal K Das is a key figure in the field of rotavirus research, with a patent that showcases his innovative contributions. His work continues to influence immunization strategies and public health policies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
